Using AI to recommend treatments for adults with skeletal Class III malocclusion
Reliability Of Artificial Intelligence for Treatment Decision Recommendation of Adult Skeletal Class III Patients: A Diagnostic Test Accuracy Study
This study is testing whether artificial intelligence can give better treatment suggestions for adults with jaw and dental issues caused by skeletal Class III malocclusion.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06002373 on ClinicalTrials.gov |
What this trial studies
This study assesses the reliability of artificial intelligence in providing treatment recommendations for adult patients with skeletal Class III malocclusion, a condition characterized by facial and dental irregularities due to jaw discrepancies. It involves collecting a diverse dataset of adult patients diagnosed with this condition and training AI algorithms on various clinical and radiographic parameters to identify patterns. The AI-generated recommendations will be compared to traditional treatment planning methods to evaluate their accuracy and dependability.
Who should consider this trial
Good fit: Ideal candidates are skeletally mature adults diagnosed with skeletal Class III malocclusion who have not undergone previous surgical interventions.
Not a fit: Patients who are skeletally immature, have pseudo class III, or present with syndromic conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more accurate and personalized treatment plans for patients with skeletal Class III malocclusion.
How similar studies have performed: While the use of AI in orthodontics is emerging, this specific application for skeletal Class III malocclusion treatment recommendations is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Skeletally mature patients with CVMI 6. * Skeletal class III patients * No congenital deformity, syndrome, or cleft. * No previous surgical intervention * No mandibular transverse functional shift. * Normal overjet, overbite after completion of treatment. * Patients with well finished occlusion. * Patients who have achieved adequate functional and aesthetic results at the end of their treatment. * Good quality initial and final lateral cephalometric radiographs. * No sex predilection. Exclusion Criteria: * Adolescents and skeletally immature patients. * Patients with pseudo class III. * Syndromic patients. * Patients with facial deformity at the naso-maxillary complex
Where this trial is running
Cairo
- Cairo University — Cairo, Egypt (Recruiting)
Study contacts
- Study coordinator: Maha AM Swelam, PhD
- Email: maha.swelam@gmail.com
- Phone: 00201123344551
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.